메뉴 건너뛰기




Volumn 142, Issue 5, 2000, Pages 931-936

Topical corticosteroid phobia in patients with atopic eczema

Author keywords

Atopic dermatitis; Phobia; Skin thinning; Topical corticosteroids

Indexed keywords

BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; FLUOCINOLONE ACETONIDE; FLUTICASONE PROPIONATE; FUSIDATE SODIUM; HYDROCORTISONE; MOMETASONE FUROATE;

EID: 0034075485     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03473.x     Document Type: Article
Times cited : (503)

References (19)
  • 1
    • 0013666093 scopus 로고
    • Topical glucocorticosteroids
    • March/April
    • 1 Yohn JJ, Weston WL. Topical glucocorticosteroids. Curr Probl Dermatol 1990; March/April: 31-63.
    • (1990) Curr Probl Dermatol , pp. 31-63
    • Yohn, J.J.1    Weston, W.L.2
  • 3
    • 0023617615 scopus 로고
    • Steroid scare
    • 3 David TJ. Steroid scare. Arch Dis Child 1987; 62: 876-8.
    • (1987) Arch Dis Child , vol.62 , pp. 876-878
    • David, T.J.1
  • 4
    • 0002732887 scopus 로고    scopus 로고
    • Compliance problems in paediatric atopic eczema
    • 4 Fischer G. Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996; 37: S10-13.
    • (1996) Australas J Dermatol , vol.37
    • Fischer, G.1
  • 5
    • 0030744127 scopus 로고    scopus 로고
    • Adult height in patients with childhood onset atopic dermatitis
    • 5 Patel L, Clayton PE, Jenney MEM et al. Adult height in patients with childhood onset atopic dermatitis. Arch Dis Child 1997; 76: 505-8.
    • (1997) Arch Dis Child , vol.76 , pp. 505-508
    • Patel, L.1    Clayton, P.E.2    Jenney, M.E.M.3
  • 6
    • 0016927925 scopus 로고
    • The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients
    • 6 Munro DD. The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients. Br J Dermatol 1976; 94 (Suppl. 12): 67-76.
    • (1976) Br J Dermatol , vol.94 , Issue.SUPPL. 12 , pp. 67-76
    • Munro, D.D.1
  • 7
    • 0023021367 scopus 로고
    • Topical corticosteroid therapy for children: Aclometasone dipropionate cream 0.05%
    • 7 Crespi HG. Topical corticosteroid therapy for children: aclometasone dipropionate cream 0.05%. Clin Ther 1986; 8: 203-10.
    • (1986) Clin Ther , vol.8 , pp. 203-210
    • Crespi, H.G.1
  • 8
    • 0030891884 scopus 로고    scopus 로고
    • Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis
    • 8 Lucky AW, Grote GD, Williams JL et al. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Cutis 1997; 59: 151-3.
    • (1997) Cutis , vol.59 , pp. 151-153
    • Lucky, A.W.1    Grote, G.D.2    Williams, J.L.3
  • 9
    • 0018098355 scopus 로고
    • Percutaneous absorption of topically applied triamcinolone in children
    • 9 Rasmussen JE. Percutaneous absorption of topically applied triamcinolone in children. Arch Dermatol 1978; 114: 1165-7.
    • (1978) Arch Dermatol , vol.114 , pp. 1165-1167
    • Rasmussen, J.E.1
  • 10
    • 0033016393 scopus 로고    scopus 로고
    • The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
    • 10 Van der Meer JB, Glazenburg EJ, Mulder PGH et al. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. Br J Dermatol 1999; 140: 1114-21.
    • (1999) Br J Dermatol , vol.140 , pp. 1114-1121
    • Van Der Meer, J.B.1    Glazenburg, E.J.2    Mulder, P.G.H.3
  • 11
    • 0025780355 scopus 로고
    • Comparison of mometasone furoate 0.01% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis
    • 11 Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.01% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24: 603-7.
    • (1991) J Am Acad Dermatol , vol.24 , pp. 603-607
    • Vernon, H.J.1    Lane, A.T.2    Weston, W.3
  • 12
    • 0018831512 scopus 로고
    • Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids
    • 12 Weston WL, Sams WM, Morris HG et al. Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids. Pediatrics 1980; 65: 103-6.
    • (1980) Pediatrics , vol.65 , pp. 103-106
    • Weston, W.L.1    Sams, W.M.2    Morris, H.G.3
  • 13
    • 0021152544 scopus 로고
    • Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood
    • 13 Queille C, Pommarede R, Saurat JH. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1984; 1: 246-53.
    • (1984) Pediatr Dermatol , vol.1 , pp. 246-253
    • Queille, C.1    Pommarede, R.2    Saurat, J.H.3
  • 14
    • 0030076217 scopus 로고    scopus 로고
    • Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema
    • 14 Juhlin L. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Cutis 1996; 57: 51-6.
    • (1996) Cutis , vol.57 , pp. 51-56
    • Juhlin, L.1
  • 15
    • 0028998556 scopus 로고
    • Adrenal function following topical steroid treatment in children with atopic dermatitis
    • 15 Patel L, Clayton PE, Addison GM et al. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995; 132: 950-5.
    • (1995) Br J Dermatol , vol.132 , pp. 950-955
    • Patel, L.1    Clayton, P.E.2    Addison, G.M.3
  • 16
    • 0028958735 scopus 로고
    • In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid us compared to other potent topical glucocorticoids old and new
    • 16 Kerscher MJ, Hart H, Korting HC et al. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid us compared to other potent topical glucocorticoids old and new. Int J Clin Pharmacol Ther 1995; 33: 187-9.
    • (1995) Int J Clin Pharmacol Ther , vol.33 , pp. 187-189
    • Kerscher, M.J.1    Hart, H.2    Korting, H.C.3
  • 17
    • 0026763933 scopus 로고
    • Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis
    • 17 Kerscher MJ, Korting HC. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. Skin Pharmacol 1992; 5: 77-80.
    • (1992) Skin Pharmacol , vol.5 , pp. 77-80
    • Kerscher, M.J.1    Korting, H.C.2
  • 18
    • 0026600859 scopus 로고
    • Topical glucocorticoids of the non-fluorinated double-ester type
    • 18 Kerscher MJ, Korting HC. Topical glucocorticoids of the non-fluorinated double-ester type. Acta Derm Venereol (Stockh) 1992; 72: 214-16.
    • (1992) Acta Derm Venereol (Stockh) , vol.72 , pp. 214-216
    • Kerscher, M.J.1    Korting, H.C.2
  • 19
    • 0026571665 scopus 로고
    • 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream
    • 19 Korting HC, Vieluf D. Kerscher M. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream. Eur J Clin Pharmacol 1992; 42: 159-61.
    • (1992) Eur J Clin Pharmacol , vol.42 , pp. 159-161
    • Korting, H.C.1    Vieluf, D.2    Kerscher, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.